DCF — ATRIUM HEALTH CLEVELAND
Enterprise Value: $-3.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-3.0M
Enterprise Value
$-8.9M
PV of Cash Flows
$5.9M
PV of Terminal Value
$9.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $315.0M | $7.3M | 2.0% | $-6.0M | $-5.5M |
| Year 2 | $324.4M | $10.8M | 3.0% | $-3.6M | $-3.0M |
| Year 3 | $334.1M | $14.4M | 4.0% | $-1.2M | $-0.9M |
| Year 4 | $344.2M | $16.6M | 5.0% | $0.0M | $0.0M |
| Year 5 | $354.5M | $18.0M | 5.0% | $0.7M | $0.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-3.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$305.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.018230229602952935
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5